Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.564.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.564.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.564.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.345NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.345NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.345NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.450NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.450NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.334NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.334NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.334NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.589NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.589NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.589NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.335NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.335NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.169NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.169NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.169NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.43NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.42NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.42NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.442NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.442NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.442NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.75NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.75NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.75NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.106NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.106NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.106NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
D.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
D.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.593NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used